Polar Asset Management Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-97,000
Closed -$967K 797
2024
Q1
$967K Buy
+97,000
New +$967K 0.02% 424